Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603)

NCT00686790 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis D, Chronic
Hepatitis B, Chronic

Interventions

BIOLOGICAL: Peginterferon alfa-2b (PegIntron, SCH 54031)

Sponsor

Merck Sharp & Dohme LLC